课题基金 / 基金详情

ANTIBODY CHELATES AND CONJUGATES

ANTIBODY CHELATES AND CONJUGATES
抗体螯合物和缀合物
批准号:
6269267
负责人:
John Ernest Shively
金额:
$23.57万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-18 至 1999-04-30

项目摘要

项目成果

John Ernest Shively的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Novel bifunctional chelates and metal ion complexes will be synthesized and conjugated to anti-CEA (carcinoembryonic antigen) antibodies for their improved targeting in CEA positive tumors. The new bifunctional chelates are based on the macrocycle DOTA and incorporate new pendant functional groups to enhance metal ion binding on the antibody conjugate. the functional groups include carboxyl, sulfhydryl, hydrazides, and acetohydroxamates. these groups are expected to form tight "type I" complexes with In-111, Y-90, nd Cu-64. The radiometals were chosen for their utility in radioimmuno-imaging and therapy. Conditions of pH, temperature, and choice of transchelator will be optimized for the conjugate for each metal ion, and stability constants for the "type I" complexes will be measured in serum. in addition the stability constants for the "type II" complexes will be measured in 10 mM DTPA. Simplified synthetic routes have been devised for each bifunctional chelator. The products will be purified by ion exchange chromatography and analyzed by mass spectrometry and NMR. The bifunctional chelators will be attached with or without linkers to whole and antibody fragments, engineered in Project 2. Non-specific attachment will be to lysine residues and site specific attachment will be to cysteine residues in the hinge region or those engineered into the CH3 domain, and to aldehydes produced by periodate oxidation of engineered glycosyl residues. Chemically labile liners that improve tumor to blood ratios without lowering tumor uptake of the sulfur atom in the linker. Animal studies will be performed to determine the ultimate metabolic fate of the metal complex ina the liver, kidney, and tumor. The overall approach is expected to lead to clinical products with improved labeling and biodistribution properties. The assembled team has unique expertise in chemistry, antibody conjugation, and the use of animal models for evaluating radiolabeled antibodies in pre-clinical and clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted radiation and immunocytokine therapy for CEA positive malignancies
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
  • 批准号:
    7982064
  • 项目类别:
  • 资助金额:
    $5.33万
  • 财政年份:
    2008
  • 负责人:
    John Ernest Shively
  • 依托单位:
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
  • 批准号:
    7716649
  • 项目类别:
  • 资助金额:
    $6.01万
  • 财政年份:
    2008
  • 负责人:
    John Ernest Shively
  • 依托单位:
OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF BREAST CANCER
  • 批准号:
    7603863
  • 项目类别:
  • 资助金额:
    $0.19万
  • 财政年份:
    2006
  • 负责人:
    John Ernest Shively
  • 依托单位:
海外基金